EMEA-001272-PIP02-13-M01
Key facts
Invented name |
Vidaza
|
Active substance |
azacitidine
|
Therapeutic area |
Haematology-Hemostaseology
|
Decision number |
P/0217/2015
|
PIP number |
EMEA-001272-PIP02-13-M01
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
|
Route(s) of administration |
|
Contact for public enquiries |
Celgene Europe Ltd
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|